Kezar Life Sciences
KZR
$0.86
Share price
0.32%
Change (1 day)
-67.15%
Change (1 year)
Categories
Kezar Life Sciences (KZR) - Cash on Hand
Cash on Hand as of December 2023 : $0.20 B
According to Kezar Life Sciences's latest financial reports the company has $0.20 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kezar Life Sciences - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.27 B | 32.74% |
| 2021-12-31 | $0.20 B | 48.35% |
| 2020-12-31 | $0.14 B | 79.59% |
| 2019-12-31 | $78.2 M | -27.2% |
| 2018-12-31 | $0.10 B | 110.51% |
| 2017-12-31 | $51.03 M | 423.58% |
| 2016-12-31 | $9.74 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 3.38% | 🇺🇸 USA |